Literature DB >> 21763005

Cleft palate, retrognathia and congenital heart disease in velo-cardio-facial syndrome: a phenotype correlation study.

Marcia A Friedman1, Nathanial Miletta, Cheryl Roe, Dongliang Wang, Bernice E Morrow, Wendy R Kates, Anne Marie Higgins, Robert J Shprintzen.   

Abstract

OBJECTIVE: Velo-cardio-facial syndrome (VCFS) is caused by a microdeletion of approximately 40 genes from one copy of chromosome 22. Expression of the syndrome is a variable combination of over 190 phenotypic characteristics. As of yet, little is known about how these phenotypes correlate with one another or whether there are predictable patterns of expression. Two of the most common phenotypic categories, congenital heart disease and cleft palate, have been proposed to have a common genetic relationship to the deleted T-box 1 gene (TBX1). The purpose of this study is to determine if congenital heart disease and cleft palate are correlated in a large cohort of human subjects with VCFS.
METHODS: This study is a retrospective chart review including 316 Caucasian non-Hispanic subjects with FISH or CGH microarray confirmed chromosome 22q11.2 deletions. All subjects were evaluated by the interdisciplinary team at the Velo-Cardio-Facial Syndrome International Center at Upstate Medical University, Syracuse, NY. Each combination of congenital heart disease, cleft palates, and retrognathia was analyzed by Chi square or Fisher exact test.
RESULTS: For all categories of congenital heart disease and cleft palate or retrognathia no significant associations were found, with the exception of submucous cleft palate and retrognathia (nominal p=0.0325) and occult submucous cleft palate and retrognathia (nominal p=0.000013).
CONCLUSIONS: Congenital heart disease and cleft palate do not appear to be correlated in human subjects with VCFS despite earlier suggestions from animal models. Possible explanations include modification of the effect of TBX1 by genes outside of the 22q11.2 region that may further influence the formation of the palate or heart, or the presence of epigenetic factors that may effect genes within the deleted region, modifying genes elsewhere, or polymorphisms on the normal copy of chromosome 22. Lastly, it is possible that TBX1 plays a role in palate formation in some species, but not in humans. In VCFS, retrognathia is caused by an obtuse angulation of the skull base. It is unknown if the correlation between retrognathia and cleft palate in VCFS indicates a developmental sequence related to skull morphology, or direct gene effects of both anomalies. Much work remains to be done to fully understand the complex relationships between phenotypic characteristics in VCFS.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21763005      PMCID: PMC3162093          DOI: 10.1016/j.ijporl.2011.06.013

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  35 in total

1.  DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1.

Authors:  L A Jerome; V E Papaioannou
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

2.  TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome.

Authors:  S Merscher; B Funke; J A Epstein; J Heyer; A Puech; M M Lu; R J Xavier; M B Demay; R G Russell; S Factor; K Tokooya; B S Jore; M Lopez; R K Pandita; M Lia; D Carrion; H Xu; H Schorle; J B Kobler; P Scambler; A Wynshaw-Boris; A I Skoultchi; B E Morrow; R Kucherlapati
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 3.  Cardiovascular anomalies associated with chromosome 22q11.2 deletion syndrome.

Authors:  Kazuo Momma
Journal:  Am J Cardiol       Date:  2010-06-01       Impact factor: 2.778

4.  Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis.

Authors:  T H Shaikh; H Kurahashi; S C Saitta; A M O'Hare; P Hu; B A Roe; D A Driscoll; D M McDonald-McGinn; E H Zackai; M L Budarf; B S Emanuel
Journal:  Hum Mol Genet       Date:  2000-03-01       Impact factor: 6.150

5.  VEGF: a modifier of the del22q11 (DiGeorge) syndrome?

Authors:  Ingeborg Stalmans; Diether Lambrechts; Frederik De Smet; Sandra Jansen; Jian Wang; Sunit Maity; Paige Kneer; Maren von der Ohe; Ann Swillen; Christa Maes; Marc Gewillig; Daniel G M Molin; Peter Hellings; Thurid Boetel; Maartin Haardt; Veerle Compernolle; Mieke Dewerchin; Stephane Plaisance; Robert Vlietinck; Beverly Emanuel; Adriana C Gittenberger-de Groot; Peter Scambler; Bernice Morrow; Deborah A Driscol; Lieve Moons; Camila V Esguerra; Geert Carmeliet; Annett Behn-Krappa; Koen Devriendt; Désiré Collen; Simon J Conway; Peter Carmeliet
Journal:  Nat Med       Date:  2003-01-21       Impact factor: 53.440

6.  Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage.

Authors:  Jun Liao; Lazaros Kochilas; Sonja Nowotschin; Jelena S Arnold; Vimla S Aggarwal; Jonathan A Epstein; M Christian Brown; Joe Adams; Bernice E Morrow
Journal:  Hum Mol Genet       Date:  2004-06-09       Impact factor: 6.150

7.  Chromosome 22q11.2 deletion and phenotypic features in 30 patients with conotruncal heart defects.

Authors:  Murat Derbent; Zerrin Yilmaz; Volkan Baltaci; Arda Saygili; Birgül Varan; Kürşat Tokel
Journal:  Am J Med Genet A       Date:  2003-01-15       Impact factor: 2.802

8.  Thickness and histologic and histochemical properties of the superior pharyngeal constrictor muscle in velocardiofacial syndrome.

Authors:  Shane Zim; Robert Schelper; Robert Kellman; Sherard Tatum; Robert Ploutz-Snyder; Robert Shprintzen
Journal:  Arch Facial Plast Surg       Date:  2003 Nov-Dec

9.  Anatomic patterns of conotruncal defects associated with deletion 22q11.

Authors:  B Marino; M C Digilio; A Toscano; S Anaclerio; A Giannotti; C Feltri; M A de Ioris; A Angioni; B Dallapiccola
Journal:  Genet Med       Date:  2001 Jan-Feb       Impact factor: 8.822

10.  A genetic link between Tbx1 and fibroblast growth factor signaling.

Authors:  Francesca Vitelli; Ilaria Taddei; Masae Morishima; Erik N Meyers; Elizabeth A Lindsay; Antonio Baldini
Journal:  Development       Date:  2002-10       Impact factor: 6.868

View more
  8 in total

1.  Ohnologs are overrepresented in pathogenic copy number mutations.

Authors:  Aoife McLysaght; Takashi Makino; Hannah M Grayton; Maria Tropeano; Kevin J Mitchell; Evangelos Vassos; David A Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-24       Impact factor: 11.205

Review 2.  Modeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit development.

Authors:  Daniel W Meechan; Thomas M Maynard; Eric S Tucker; Alejandra Fernandez; Beverly A Karpinski; Lawrence A Rothblat; Anthony-S LaMantia
Journal:  Prog Neurobiol       Date:  2015-04-09       Impact factor: 11.685

3.  Dysphagia and disrupted cranial nerve development in a mouse model of DiGeorge (22q11) deletion syndrome.

Authors:  Beverly A Karpinski; Thomas M Maynard; Matthew S Fralish; Samer Nuwayhid; Irene E Zohn; Sally A Moody; Anthony-S LaMantia
Journal:  Dis Model Mech       Date:  2013-12-19       Impact factor: 5.758

4.  The prevalence of non-syndromic orofacial clefts and associated congenital heart diseases of a tertiary hospital in Riyadh, Saudi Arabia.

Authors:  Ziyad AlHammad; Ihab Suliman; Sami Alotaibi; Hourya Alnofaie; Waad Alsaadi; Sarah Alhusseini; Ghadah Aldakheel; Noura Alsubaie
Journal:  Saudi Dent J       Date:  2019-12-19

5.  A unique case of uncorrected Fallot's tetralogy with nasal dermoid cyst and median cleft lip presenting during postpartum.

Authors:  Subhankar Chatterjee; Umesh K Ojha; Suraj H Chavan; Diksha Singh; Priyanshu Kumari; Kunal Kumar; Ramsha Shafi; Surendra Baskey; Rituparna Dasgupta; Julián Benito-León; Ritwik Ghosh
Journal:  J Family Med Prim Care       Date:  2022-01-31

6.  Characteristic face: a key indicator for direct diagnosis of 22q11.2 deletions in Chinese velocardiofacial syndrome patients.

Authors:  Dandan Wu; Yang Chen; Chen Xu; Ke Wang; Huijun Wang; Fengyun Zheng; Duan Ma; Guomin Wang
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

7.  The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis.

Authors:  Olga Catalina-Rodriguez; Vamsi K Kolukula; York Tomita; Anju Preet; Ferdinando Palmieri; Anton Wellstein; Stephen Byers; Amato J Giaccia; Eric Glasgow; Chris Albanese; Maria Laura Avantaggiati
Journal:  Oncotarget       Date:  2012-10

8.  A case report of 22q11 deletion syndrome confirmed by array-CGH method.

Authors:  Maryam Sedghi; Narges Nouri; Hossein Abdali; Mehrdad Memarzadeh; Nayereh Nouri
Journal:  J Res Med Sci       Date:  2012-03       Impact factor: 1.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.